Real-world effectiveness and safety of lanadelumab for prophylaxis of hereditary angioedema attacks: 2-year interim results from the enable study

被引：0
|
作者：
Saguer, I. Martinez [1 ]
Cancian, M. [2 ]
Kinaciyan, T. [3 ]
Kessel, A. [4 ]
Andriotti, T. [5 ]
Botha, J. [6 ]
Wuillemin, W. [7 ,8 ]
机构：
[1] HRZM Hemophilia Ctr Rhein Main, Morfelden Walldorf, Germany
[2] Univ Hosp Padua, Padua, Italy
[3] Med Univ Vienna, Vienna, Austria
[4] Technion Fac Med, Bnai Zion Med Ctr, Haifa, Israel
[5] Takeda Dev Ctr Amer Inc, Lexington, KY USA
[6] Takeda Pharmaceut Int AG, Zurich, Switzerland
[7] Luzerner Kantonsspital, Luzern, Switzerland
[8] Univ Bern, Bern, Switzerland
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000847
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [21] Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study
    Nielsen, Jimmi
    Kane, John M.
    Correll, Christoph U.
    BIPOLAR DISORDERS, 2012, 14 (08) : 863 - 869
  • [22] Efficacy and safety of Cinryze for the prevention of hereditary angioedema attacks in children: interim results of a Phase 3 study
    Aygoren-Pursun, E.
    Moldovan, D.
    Christensen, J.
    van, Leerberghe A.
    Wu, Y.
    Schranz, J.
    Martinez-Saguer, I
    Soteres, D.
    ALLERGY, 2016, 71 : 296 - 296
  • [23] P96 Effectiveness and safety of bimekizumab for adult patients with plaque psoriasis: an interim analysis of 2-year data from a real-world, multicentre, retrospective study
    Sood, Siddhartha
    Rimke, Alexander
    Rankin, Brian
    Abduelmula, Abrahim
    Georgakopoulos, Jorge
    Maliyar, Khalad
    Bagit, Ahmed
    Leung, Fernejoy
    Devani, Alim
    Vender, Ronald
    Yeung, Jensen
    Prajapati, Vimal
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [24] Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies
    Craig, Timothy J.
    Zaragoza-Urdaz, Rafael H.
    Li, H. Henry
    Yu, Ming
    Ren, Hong
    Juethner, Salome
    Anderson, John
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01):
  • [25] Effectiveness of vortioxetine in real-world clinical practice: Interim results from the relieve study
    Mattingly, G.
    Christensen, M.
    Simonsen, K.
    Hammer-Helmich, L.
    Ren, H.
    EUROPEAN PSYCHIATRY, 2021, 64 : S341 - S341
  • [26] Quality of life during lanadelumab treatment in patients with hereditary angioedema: 24-month results from the enable study
    Saguer, I. Martinez
    Magerl, M.
    Andriotti, T.
    Botha, J.
    Agmon-Levin, N.
    Watt, M.
    Maurer, M.
    ALLERGY, 2023, 78 : 26 - 27
  • [27] Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies
    Timothy J. Craig
    Rafael H. Zaragoza-Urdaz
    H. Henry Li
    Ming Yu
    Hong Ren
    Salomé Juethner
    John Anderson
    Allergy, Asthma & Clinical Immunology, 18
  • [28] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
    Eric L. Simpson
    Ben Lockshin
    Lara Wine Lee
    Zhen Chen
    Moataz Daoud
    Andrew Korotzer
    Dermatology and Therapy, 2024, 14 : 261 - 270
  • [29] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
    Simpson, Eric L.
    Lockshin, Ben
    Lee, Lara Wine
    Chen, Zhen
    Daoud, Moataz
    Korotzer, Andrew
    DERMATOLOGY AND THERAPY, 2024, 14 (01) : 261 - 270
  • [30] Lanadelumab reduces high morbidity attacks in patients with hereditary angioedema (HAE): results from the phase 3 HELP study
    Bernstein, J. A.
    Banerji, A.
    Schranz, J.
    Nurse, C.
    Riedl, M.
    Lu, P.
    ALLERGY, 2018, 73 : 288 - 289
12345